Should I Have an Ablation for PVCs?

Ablation for premature ventricular contractions makes the most sense when those extra beats are frequent enough to risk weakening the heart muscle, when they cause symptoms that medications cannot adequately control, or when drug side effects become their own problem. For many people with occasional PVCs and no sign of heart damage, watchful waiting or lifestyle changes are enough. The procedure is not a blanket recommendation for anyone who feels a skipped beat, but when the PVC burden climbs into worrying territory or heart function starts to slip, ablation offers something medications generally cannot: a durable fix with a realistic chance of eliminating the problem rather than just dampening it.

Why PVC Burden Is the Number That Matters Most

If you have been told you have PVCs, the single most important piece of information is how many you are having relative to your total heartbeats over a 24-hour period. That percentage is your PVC burden. A burden above roughly 20 to 24 percent has been identified as a cutoff for predicting who is at risk of developing PVC-induced cardiomyopathy, a condition where the extra beats gradually weaken the heart’s pumping ability. One study found that threshold had about 79 percent sensitivity and 78 percent specificity for identifying at-risk patients. But the same research also identified a patient whose heart weakened at just a 10 percent burden, and other work has documented cardiomyopathy developing at burdens as low as 5 to 6 percent.¹ That reality means there is no single magic number. Electrophysiologists generally start paying close attention once PVC burden crosses about 10 percent, and they watch carefully for any sign of declining heart function even below that threshold.

A large meta-analysis pooling data from over 16 million patients found that PVC burden was a significant independent risk factor for developing cardiomyopathy, but it was not the only one. Older age, the presence of short runs of faster rhythms, PVCs originating from the left ventricle or the outer surface of the heart, wider PVC complexes on the ECG, and a particular pattern called interpolation (where the PVC wedges between two normal beats without resetting the rhythm) all independently increased the odds of the heart weakening.² One somewhat counterintuitive finding from that analysis was that having symptoms actually lowered the odds of cardiomyopathy. The likely explanation is that symptomatic patients seek treatment earlier, before the heart has time to remodel. If you feel every skipped beat and it bothers you enough to see a doctor, you may paradoxically be in a safer position than someone whose PVCs are silently accumulating without any warning signs.

The Case for Ablation When the Heart Is Already Weakening

PVC-induced cardiomyopathy is one of the strongest arguments for ablation because it is a potentially reversible condition. The heart muscle has not been permanently scarred; it has been overworked and thrown off rhythm by constant extra beats. Remove those beats, and the heart often recovers.³ In a study of 75 patients with PVC-related heart dysfunction who underwent ablation, the ejection fraction normalized at an average of about five months after the procedure. About two-thirds of patients recovered within four months. The remaining third took longer, sometimes up to several years, but still ultimately improved.⁴ A cardiac MRI study of patients who underwent ablation found that nearly 80 percent of those with reduced pumping function before the procedure recovered afterward.⁵

The stakes are even higher for patients with existing structural heart disease. In people with ischemic or non-ischemic cardiomyopathy and a high PVC burden, successful ablation has been shown to improve ejection fraction by 8 to 12 percentage points on average in non-ischemic cases and to improve functional status across the board. In one study of patients who met criteria for a prophylactic defibrillator because their ejection fraction was so low, ablation of frequent PVCs improved pumping function from an average of 28 percent to 42 percent at 12 months, and about 64 percent of those patients no longer needed the defibrillator at all.⁶ That is a meaningful outcome: avoiding a permanently implanted device by fixing the underlying rhythm problem.

Ablation Compared to Medication

Antiarrhythmic drugs are usually the first-line treatment for bothersome PVCs. They can reduce burden and ease symptoms. But they come with their own problems, including side effects that sometimes rival the PVCs themselves. A systematic review comparing catheter ablation to drug therapy found that ablation appeared superior for PVC recurrence, frequency, and burden. Complication rates for the procedure ranged from 0 to about 6 percent, while adverse event rates from medications ran between roughly 10 and 21 percent.⁷ That difference is striking. Medications carry ongoing exposure to side effects for as long as you take them, while ablation is a one-time procedure.

A prospective randomized trial of patients with frequent PVCs originating from the right ventricular outflow tract, the single most common location, put numbers on the comparison directly. During a one-year follow-up, PVC recurrence was about 19 percent in the ablation group versus nearly 89 percent in the medication group. Ablation was associated with a dramatically greater reduction in PVC burden.⁸ These numbers explain why electrophysiologists often recommend moving to ablation relatively early for patients with right outflow tract PVCs who have a high burden or are already showing symptoms, rather than cycling through multiple medications first.

Where PVCs Come From Changes the Odds

Not all PVC ablations are created equal. The heart’s anatomy means some origin sites are straightforward to reach and treat, while others sit in tricky neighborhoods near critical structures. PVCs from the right ventricular outflow tract and left ventricular outflow tract, the two most common locations, have excellent success rates. One analysis found success rates of 98 percent and 97 percent for right and left outflow tract origins respectively, with no major complications in that group.⁹ A study using zero-fluoroscopy techniques, where the procedure is guided entirely by electroanatomical mapping rather than X-ray, reported long-term success rates of about 91 percent for right outflow tract PVCs and 85 percent for non-outflow tract locations.¹⁰

The picture changes for PVCs arising from certain difficult-to-reach areas. PVCs from the coronary sinus or left ventricular summit had a success rate of only about 29 percent in one series, and PVCs from near the His bundle, the heart’s main electrical cable, had zero acute success with standard radiofrequency energy in the same study.⁹ These locations require specialized techniques or alternative energy sources. If your electrophysiologist tells you the PVC origin is in a challenging spot, the conversation about whether ablation is worth pursuing becomes more nuanced, and the answer may genuinely be to try medication first or to seek out a center with particular expertise.

What the Risks Actually Look Like

Any invasive procedure carries risk, and PVC ablation is no exception. A multicenter study of nearly 1,200 patients found an overall complication rate of about 5 percent, with major complications occurring in roughly 2.4 percent of cases. The most common issues involved the groin access site. About 0.8 percent of patients developed cardiac tamponade, a buildup of fluid around the heart requiring drainage. One patient developed permanent heart block. No strokes or deaths occurred in that cohort.¹¹

A separate large study that included patients with and without structural heart disease found a major complication rate of about 4.4 percent overall, but the rate was much lower, around 1.8 percent, in patients with structurally normal hearts. Patients with underlying heart disease faced about a 6 percent major complication rate. Cardiac tamponade was again the most common serious event. That study did report a 1.8 percent in-hospital mortality rate, though this included a sicker population with pre-existing cardiac disease undergoing ventricular arrhythmia ablation broadly, not just isolated PVC ablation.¹² A Chinese registry study of PVC ablation in patients without structural heart disease reported an overall complication rate of 2.7 percent, with major cardiac events in 1.5 percent and two procedure-related deaths out of over 1,200 cases, for a mortality rate of 0.16 percent.¹³

The practical takeaway is that PVC ablation in otherwise healthy hearts is quite safe but not risk-free. Your risk profile shifts based on where the PVCs originate, whether ablation needs to access the left side of the heart or the outer surface, and whether you have underlying heart disease or are on blood thinners.

Long-Term Success and the Possibility of Recurrence

Ablation is effective, but it is not a guaranteed permanent cure. A study following 241 patients found that about 67 percent had long-term success at a median follow-up of roughly 18 months. Factors that predicted better outcomes included female sex, PVCs originating from the right ventricle, having only a single PVC shape on monitoring, and shorter ablation times during the procedure. Diabetes and alcohol use were associated with a higher chance of recurrence.¹⁴

An interesting wrinkle emerged from a study that tracked recurrence patterns over three years. Overall long-term success was 75 percent. But among the quarter of patients who did have recurrences, only about 7 percent were from the original spot that was ablated. The majority of recurrences came from an entirely new location in the heart, and those new-source recurrences tended to appear much later, around three years out on average, compared to true re-emergence from the original focus, which happened within the first several months.¹⁵ This means the ablation itself usually does its job. When PVCs come back years later, it is often because a new irritable focus has developed elsewhere, not because the original treatment failed. A second ablation is possible in those cases, and many patients pursue it.

The Diagnostic Work Before the Decision

Before anyone should be deciding about ablation, there is a workup that should happen first. An ECG can reveal the PVC morphology, which gives a rough idea of where the extra beats are coming from. An echocardiogram checks whether the heart’s structure and pumping function are normal. Ambulatory monitoring, typically a Holter monitor worn for 24 to 48 hours or a longer-term patch monitor, is essential for quantifying PVC burden accurately.¹⁶

Cardiac MRI deserves special mention. A study of 51 patients who all had high PVC burdens (over 10,000 PVCs per day) and completely normal echocardiograms and exercise tests found that about a third showed structural heart abnormalities on MRI, including fibrosis, regional wall motion problems, and impaired ejection fraction that the echocardiogram had missed.¹⁷ This is clinically important for two reasons. First, hidden structural disease changes the risk profile of both the PVCs themselves and the ablation procedure. Second, finding fibrosis or other abnormalities might indicate that the PVCs are a symptom of an underlying condition rather than the primary problem. If your PVC burden is high and your echo looks normal, pushing for an MRI before committing to any treatment plan is reasonable.

When Ablation Might Not Be Necessary

Not everyone with PVCs needs a procedure. If your burden is low, your heart function is normal, and the PVCs are not ruining your quality of life, watchful monitoring may be all that is needed. Several modifiable factors are associated with PVC frequency, including smoking, being sedentary, hypertension, and low magnesium levels.¹⁸ Stress is another contributor; one study found that people reporting psychosocial stress were about nine times more likely to have PVCs during the recovery phase of a treadmill test compared to unstressed individuals.¹⁹

Addressing these triggers does not guarantee the PVCs will disappear, but for many people with modest burdens, improving sleep, managing stress, exercising regularly, and correcting electrolyte imbalances can reduce PVC frequency enough to make the question of ablation moot. The key is ongoing monitoring: if you and your doctor agree on a conservative approach, periodic Holter monitoring and echocardiograms ensure nothing is sneaking up on you.

Specialized Techniques for Difficult Locations

When PVCs originate near the His bundle, using standard radiofrequency energy risks damaging the heart’s main electrical wiring and causing permanent heart block, which would require a pacemaker. For these cases, cryoablation offers an advantage. Freezing tissue is inherently reversible at certain temperatures, allowing the electrophysiologist to do a test application and confirm the PVCs are suppressed without injuring nearby conduction tissue before committing to a permanent lesion. Cryoablation also causes less damage to the inner lining of the heart and produces less blood clot formation than heat-based energy.²⁰ A recent case report demonstrated successful cryoablation of parahisian PVCs using high-density mapping to pinpoint the origin precisely, eliminating the PVCs without any conduction disturbances and maintaining success at 12 months.²¹

Another emerging option is pulsed field ablation, which uses short electrical pulses to destroy heart tissue in a way that tends to spare surrounding non-cardiac structures like nerves, the esophagus, and coronary arteries. Early multicenter results for focal pulsed field ablation of PVCs showed an 85 percent chronic success rate, with a significant reduction in electrical signals at the ablation site. The technology is still in its early clinical phase for PVCs, but it may eventually expand the range of locations that can be safely ablated.

Quality of Life and the Symptom Burden Question

The medical conversation about PVC ablation tends to center on ejection fraction and cardiomyopathy risk, but for many patients the main issue is simply feeling terrible. The sensation of constant skipped beats, chest thumping, breathlessness, fatigue, and the anxiety that comes with an irregular heartbeat can be profoundly disruptive even when the heart itself is structurally fine. Data from a large ablation registry found that PVC ablation led to significant improvements in physical functioning, energy levels, social functioning, and the ability to carry out daily physical roles.²² These quality-of-life gains matter. A patient whose PVC burden is 12 percent, whose echo is normal, but who cannot sleep through the night or concentrate at work because of palpitations may be a reasonable candidate for ablation even if their cardiomyopathy risk is modest.

This is where the decision becomes personal. There is no universal threshold where ablation becomes mandatory. Some people tolerate a 15 percent PVC burden without noticing a thing. Others are miserable at 5 percent. If medications are not controlling your symptoms or you cannot tolerate their side effects, ablation becomes a legitimate option for symptom relief alone, assuming your PVCs originate from a location with good success rates and the procedure can be done safely.

The Cost Conversation

Ablation is more expensive upfront than starting a medication. A cost-effectiveness analysis from a Peruvian health system context found that ablation using three-dimensional electroanatomical mapping cost roughly $7,200 over four years compared to about $2,100 for drug therapy. However, the ablation group accumulated more quality-adjusted life years, and when the analysis was extended to match life expectancy projections, the ablation group’s cost per quality-adjusted year dropped substantially below the drug therapy group’s.²³ In the United States, a cost-effectiveness analysis from the CABANA trial on atrial fibrillation ablation (a reasonable proxy for the economic structure of catheter ablation procedures generally) found that ablation costs about $19,000 more than drug therapy over five years but yields slightly more quality-adjusted years of life.²⁴ For someone facing decades of daily medication with its associated side effects and monitoring costs, ablation’s higher one-time price tag may be the more economical path over a lifetime.

Children and Adolescents With Frequent PVCs

PVC ablation in children and teenagers presents distinct challenges. Smaller body size, delicate blood vessels, and the proximity of developing cardiac structures all complicate the procedure. The substrates that cause ventricular arrhythmias in children often differ from those in adults, requiring tailored mapping and ablation strategies. Additionally, there is a particular concern about creating lesions in a heart that is still growing: scar tissue placed during childhood could potentially cause problems decades later as the heart enlarges and matures. For these reasons, pediatric electrophysiologists tend to be more conservative, reserving ablation for children with very high PVC burdens, declining heart function, or severe symptoms that have not responded to medical therapy. When the decision is made to proceed, these cases are best handled at specialized centers with pediatric electrophysiology expertise.

What Patients Think About the Procedure

A cross-sectional study examining patient attitudes toward PVC treatment found that when asked whether they would accept radiofrequency ablation if recommended, roughly 74 percent said “always” or “often,” about 13 percent said “sometimes,” and the remaining 13 percent said “rarely” or “never.” These numbers suggest that most patients are open to the idea when their doctor raises it, but a meaningful minority has reservations. If you fall into that skeptical group, understanding the specific success rates for your PVC location, the actual complication risks in your clinical context, and the concrete trajectory of what happens if PVCs are left untreated can help turn an abstract fear into an informed decision. Asking your electrophysiologist for their personal success and complication numbers for your specific type of PVC, rather than relying on general statistics, is one of the most useful things you can do before committing to or declining the procedure.